July 10th 2025, 1:00pm
By Olalekan O. Oluwole
Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and leukemia.
July 9th 2025, 9:00pm
By Dr. Dinesh Raj Neupane
Breast cancer care differs around the world, revealing urgent unmet needs in Nepal, where access, support, and treatment remain out of reach for many.
July 9th 2025, 8:00pm
By Dr. Breelyn Wilky
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses; however, molecular testing can help guides treatment decisions.
July 9th 2025, 7:00pm
By Spencer Feldman
Daniel Jernazian, a two-time cancer survivor, shares how sports, advocacy and meeting his idol shaped his journey through illness and recovery.
July 9th 2025, 5:00pm
By Mary Sansone
I celebrated five years since my bone marrow transplant with a surprise video from my donor, a beautiful reminder of the life she helped me keep.
July 9th 2025, 4:00pm
By Kristie L. Kahl
Dr. Alicia Arnold and Dr. Priyanka Raval discuss first- and later-line treatment options for those with ER-positive, HER2-negative stage 4 breast cancer.
July 9th 2025, 3:00pm
Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available in the U.S. for variois cancers and cancer-related bone conditions.
July 9th 2025, 1:00pm
By Mark Daniels
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.
July 8th 2025, 9:00pm
By Bonnie Annis
After eleven 11 of survivorship, I’ve been waiting to hear the words, “You’re completely free of cancer! Go in peace,” but I’m wondering if it ever will happen.
July 8th 2025, 8:00pm
By Dr. Vincent Ma
Ongoing research within the advanced-stage melanoma therapeutic space is beginning to suggest that shorter treatment periods may be sufficient for some.
July 8th 2025, 7:00pm
By Ryan Scott
Valarie Traynham sat down for an interview in CURE in which she discussed adjusting to life after cancer, detailing her ‘new normal.’
July 8th 2025, 5:00pm
Dr. Alexandra Zaleta discussed the impact of administrative delays and insurance red tape experienced by patients with advanced cancer.
July 8th 2025, 4:00pm
By Laura Yeager
My cancer journey taught me that nothing is certain; however, with support, humor and acceptance, we can weather the ups and downs.
July 8th 2025, 3:00pm
In a phase 2 study, 52% of patients treated with Bria-IMT plus a checkpoint inhibitor for metastatic breast cancer were alive at one year.
July 8th 2025, 1:00pm
By Maureen McBeth
Prehabilitation and early screening, including BIS, can ease recovery, reduce side effects and help manage lymphedema after breast cancer treatment.
Top Blood Cancer Stories from October: Key Updates for Patients
Expert Explains Need for Better Outcomes in Resectable Lung Cancer
Shining a Spotlight on Pinups4Cancer
Trodelvy Misses Primary Endpoint in ASCENT-07 Breast Cancer Trial